Previous Page  9 / 26 Next Page
Information
Show Menu
Previous Page 9 / 26 Next Page
Page Background

Volume 6, Issue 5 (Suppl)

J Nutr Food Sci

ISSN:2155-9600 JNFS, an open access journal

Page 61

Notes:

Nutrition 2016

September 14-16, 2016

conferenceseries

.com

September 14-16, 2016 San Antonio, USA

6

th

International Conference and Exhibition on

Nutrition

Li-Chun Lin, J Nutr Food Sci 2016, 6:5 (Suppl)

http://dx.doi.org/10.4172/2155-9600.C1.027

Isoliquiritigenin chemosensitizes to Doxorubicin and inhibits the cells growth of human uterine sarcoma cells

Li-Chun Lin

Taipei Medical University of Nutrition and Health Sciences, Taiwan

D

oxorubicin (Dox) is widely used for the treatment of several cancers. However, multi-drug resistance (MDR) is a major clinical

problem and an important cause of treatment failure. How to increase chemosensitivity and reduce the dose of chemotherapeutic

agents, in order to prevent drug side effects and the development of new chemotherapeutic agents are important. Uterine sarcoma is

a rare gynecologic cancer. The patients sometimes are asymptomatic. It has the high degree of malignancy, poor prognosis and high

mortality rate. It can often be misdiagnosed as uterine fibroids. Isoliquiritigenin (ISL) is the flavonoid with chalcone structure isolated

from licorice root. ISL has been shown to possess significant anticancer activities in many cancer types. In this study, we investigated

the antitumor effects of ISL on human uterine sarcoma cancer cell MES-SA and the multi-drug resistant human uterine sarcoma

cancer cell MES-SA/Dx5 and MES-SA/DxR-1. Our present results showed that, treatment of ISL alone or combination with Dox

significantly inhibited the growth of cancer cells and increased the proportion of subG1 phase. Flow cytometry analysis indicated that

ISL induced apoptosis and necrosis. In addition, ISL enhanced the autophagy associated protein expression of LC3B and apoptosis

associated protein expression of cleaved-PARP. ISL also inhibited Bcl-2 and phospho-mTOR protein expression. Moreover, ISL

inhibited the migration of the cancer cells. Taken together, ISL can inhibit human uterine sarcoma cancer cells through apoptosis

as well as autophagy and increase the chemosensitivity to doxorubicin in multi-drug resistant human uterine sarcoma cancer cells

MES-SA/Dx5 and MES-SA/DxR-1.

Biography

Li-Chun Lin is currently a graduate student from Taipei Medical University of Nutrition and Health Sciences, Taiwan. She studies the effects of Chinese herbs and

phytochemicals on cancer disease.

lisa81318@gmail.com